The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

Richard J. Santen, Steven J. Santner, BONNIE DAVIS et al. · The Journal of Clinical Endocrinology & Metabolism · 1978 · 341 citations

Life Sciences, Endocrinology, Pharmacology +17

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Mitch Dowsett, Paul E. Goss, TJ Powles et al. · PubMed · 1987 · 240 citations

Medicine, Oncology, Pharmacology +17

Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast Carcinoma

Richard J. Santen, Thomas J. Worgul, Allan Lipton et al. · Annals of Internal Medicine · 1982 · 171 citations

Medicine, Endocrinology, Oncology +17

Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.

Mitch Dowsett, David Cunningham, Robert C. Stein et al. · PubMed · 1989 · 141 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer

FA MacNeill, AL Jones, S. Jacobs et al. · British Journal of Cancer · 1992 · 92 citations · Full text

Medicine, Oncology, Pharmacology +7